about
sameAs
Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosisReview of the novelties from the 31st ECTRIMS Congress, 2015, presented at the 8th Post-ECTRIMS meetingBiomarkers in multiple sclerosis: an update for 2014Lack of association between hepatitis G virus and multiple sclerosisA type I interferon signature in monocytes is associated with poor response to interferon-beta in multiple sclerosisBody fluid biomarkers in multiple sclerosisDifferential diagnosis of suspected multiple sclerosis: a consensus approachMRI characteristics of atypical idiopathic inflammatory demyelinating lesions of the brainPregnancy, sex and hormonal factors in multiple sclerosis.[Recommendations for the clinical use of motor evoked potentials in multiple sclerosis].The pros and cons of early treatment of relapsing forms of multiple sclerosis.Treating relapsing-remitting multiple sclerosis: therapy effects on brain atrophy.Influence of the LILRA3 Deletion on Multiple Sclerosis Risk: Original Data and Meta-Analysis.Clinically isolated syndromes suggestive of multiple sclerosis, part 2: non-conventional MRI, recovery processes, and management.Precision medicine in multiple sclerosis: biomarkers for diagnosis, prognosis, and treatment response.[Demyelinating lesions as incidental findings in magnetic resonance imaging: a study of 11 cases with clinico-radiological follow-up and a review of the literature].Primary progressive multiple sclerosis.Multiple sclerosis: more pieces of the immunological puzzle.Identification of a novel risk locus for multiple sclerosis at 13q31.3 by a pooled genome-wide scan of 500,000 single nucleotide polymorphismsAncient and recent selective pressures shaped genetic diversity at AIM2-like nucleic acid sensors.Regulatory lymphocytes are key factors in MHC-independent resistance to EAEPeripheral neuropathy in association with insulinoma: clinical features and neuropathology of a new caseElevated Epstein-Barr virus-encoded nuclear antigen-1 immune responses predict conversion to multiple sclerosisSearch for specific biomarkers of IFNβ bioactivity in patients with multiple sclerosis.Hsp70 regulates immune response in experimental autoimmune encephalomyelitisEarly detection of neutralizing antibodies to interferon-beta in multiple sclerosis patients: binding antibodies predict neutralizing antibody development.T2 lesion location really matters: a 10 year follow-up study in primary progressive multiple sclerosis.Immunoglobulin M oligoclonal bands: biomarker of targetable inflammation in primary progressive multiple sclerosis.Long-term impact of interferon beta-1b in patients with CIS: 8-year follow-up of BENEFIT.Lipid-specific immunoglobulin M bands in cerebrospinal fluid are associated with a reduced risk of developing progressive multifocal leukoencephalopathy during treatment with natalizumab.Validation of semaphorin 7A and ala-β-his-dipeptidase as biomarkers associated with the conversion from clinically isolated syndrome to multiple sclerosisRole of magnetic resonance imaging within diagnostic criteria for multiple sclerosis.Clinical impact of intravenous methylprednisolone in attacks of multiple sclerosis.Fingolimod for relapsing multiple sclerosis: an update.A randomized, double-blind, placebo-controlled, parallel-group, enriched-design study of nabiximols* (Sativex(®) ), as add-on therapy, in subjects with refractory spasticity caused by multiple sclerosis.Baseline gene expression signatures in monocytes from multiple sclerosis patients treated with interferon-betaNatalizumab-related anaphylactoid reactions in MS patients are associated with HLA class II alleles.Genome-wide pharmacogenomic analysis of the response to interferon beta therapy in multiple sclerosis.Will Rogers phenomenon in multiple sclerosis.Risk acceptance in multiple sclerosis patients on natalizumab treatment.
P50
Q24635370-49856C0B-9C7F-4E0D-84BF-FE36E7DD097AQ26748516-55691A57-B1DC-40B6-A91F-A1AEB56B7851Q26826819-703EAF10-EEEB-4AFA-8FF3-C4C118D70298Q27485035-7F22CCC2-19D8-472B-99D6-E332A409EC98Q28257957-2B5C6163-7644-4094-BDBB-6D89FE374D60Q28303860-47E48D42-BB38-4E67-B552-EDC545AD5E34Q29039412-94C77FEA-79DC-40D0-B8CD-3C59DDD0D576Q30049081-7BF71F31-0427-4AD8-A983-DBADD285CF96Q30354175-0F54F93A-3CCB-4369-9A5D-6EEF2FD07DA1Q30569210-0E787616-6638-4DAB-8429-7499A5831D2FQ30960720-31B6F8E9-1440-4048-9219-FE64AD85FDF0Q30965003-279F6489-91C0-4740-BDC0-AA63FAD2FBE8Q30987368-3F25ECA0-7D7D-4303-9961-45C48B0F9078Q30990327-35B4AA94-A29B-4674-B70A-01E845A79C56Q31076601-0ACA4896-3B5B-49A0-8D89-904BEC210C30Q33158982-E1FD2161-3334-4B5B-B1A5-915E65DF28EFQ33215007-07A492CD-CAE9-4905-8469-8B2CD172E5CCQ33352704-44DB08EE-3ED4-4D4B-8F8E-4B536D703D2EQ33378475-5166AD1C-057E-4DCF-9659-893ACEF70C21Q33556686-7FFCEB3F-1F55-4EFD-9198-CC73B98C6574Q33608305-0A8EBD14-7501-418F-BF10-900BF4330779Q33732993-B0C63E56-9FE3-4997-8B3E-3FA964D8E0CEQ33764503-531E35FC-C3A8-4F46-8277-C6C2ABE70D74Q34008878-89996FF2-0A4D-41A7-BB2E-8BA7E38426F5Q34083865-0FA78F14-396D-42E1-9C2B-C55838B9B07FQ34368959-460FD8A9-47C5-4C3E-9762-458DB9F8198FQ34410090-E831EF42-5A7D-4059-9F91-FF440A45B87BQ34423587-BCFF4132-E413-4EF3-8436-BC03DD8D5179Q34431275-05027219-A2E9-48FA-B26F-A8DBCA3D600AQ34457797-9C8DACC2-87C0-4CD2-9D2D-544DB3029F40Q34537574-044B2739-A17A-4C54-B7FC-857640BEB034Q34549854-EAA810A0-54D8-43C8-8B7B-2D219C70ACE5Q34550413-9B01EA4E-E250-4395-8F5F-2FB15F2AC20AQ34618474-3129B060-4EEE-4B88-9BEA-0DFD5635DA63Q34627272-B2D52C22-A139-46C9-A615-DB09BA931BE3Q34700070-EABE1BF9-3236-4C79-8F19-A6A8755624AFQ34714531-E099BEBF-8B41-467B-B3FF-033B69DAC974Q34736044-8C8C3135-DF11-4402-B242-5B44076788F2Q34805875-3CC416E6-4C01-4795-91DC-C811A4F491F3Q35067882-11E33AAE-1101-4E0F-ADE0-4320EEF48DC4
P50
description
researcher ORCID ID = 0000-0002-0098-9918
@en
wetenschapper
@nl
name
Montalban X
@ast
Xavier Montalban
@en
Xavier Montalban
@es
Xavier Montalban
@nl
type
label
Montalban X
@ast
Xavier Montalban
@en
Xavier Montalban
@es
Xavier Montalban
@nl
altLabel
Montalban X
@en
Xavier Montalban Gairín
@en
prefLabel
Montalban X
@ast
Xavier Montalban
@en
Xavier Montalban
@es
Xavier Montalban
@nl
P108
P214
P1053
J-5938-2016
P106
P1580
P21
P214
P31
P4012
P496
0000-0002-0098-9918
P735
P7859
viaf-305878746